PAR 41.5% 46.0¢ paradigm biopharmaceuticals limited..

FA bagger potential, page-43

  1. 52 Posts.
    lightbulb Created with Sketch. 14
    Interesting trading on this one lately. Something that has been in top draw is getting a lot of attention with my understanding hitting some of the best thematics going around: Assisting the ageing population (helping people put off knee replacements etc and getting older people active and reducing their pain) and addressing the opioid epidemic (appears they've got a non-opioid, safe, pain treatment that treats the cause not just masking the pain).
    There's an interesting comparison with a US company FLXN that has just got an into the knee corticosteroid injection for OA pain approved by the FDA, same target indication as PAR, and get this.... its market cap is north of US$1 billion. Plenty of room for the share price to keep going up on this one, especially considering they'll get all the help in world from the FDA as they're non opioid and non steroid.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.135(41.5%)
Mkt cap ! $82.30M
Open High Low Value Volume
34.0¢ 49.5¢ 34.0¢ $3.506M 8.474M

Buyers (Bids)

No. Vol. Price($)
1 10000 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 147167 1
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.